Biotech Values

[DewDiligence]

The Grifols-TLCR deal is official: buyout price is $26.16 in cash and stock ($3.4B), a 64% premium to TLCR’s closing price on 6/4/10:

http://finance.yahoo.com/news/Grifols-to-Acquire-Talecris-prnews-3040354336.html?x=0&.v=1

This deal is curious insofar as a company based in one of the weakest European countries—Spain—is buying a US company at a time when the US dollar is especially strong against the Euro. This shows the danger of over-generalizing about these sorts of “macro” issues.

CC on the merger at 4am ET (10am Barcelona time).